Lithuanian medtech BrachyDOSE raises €554,000 to test radiation measurement tech in clinics

BrachyDOSE, a Lithuanian medtech startup, has secured €554,000 in funding to test its radiation measurement technology in a clinical environment. The round was led by Coinvest Capital, with participation from BSV Ventures and business angel networks LitBAN and EstBAN.

About BrachyDOSE

• BrachyDOSE, founded by Neringa Šeperienė and Rhymes Šeperys, is a patient-centric tool designed to prevent treatment-caused injuries in radiotherapy. 

• Combining hardware and software, it includes a radiation dose sensor and a reading device for data retrieval, alongside a deep learning algorithm to predict potential injuries. 

• By reducing treatment costs and saving time for medical professionals, BrachyDOSE aims to improve cancer treatment efficiency, enabling patients to recover more quickly and safely.

“This investment is a major boost that gives the BrachyDOSE team the opportunity to pursue our goal of helping cancer patients avoid the side effects of radiotherapy, while enabling hospitals and doctors to significantly improve the quality of cancer treatment. Once we obtain CE/MDR certification, we will be able to offer our product to both Lithuanian and international markets,” said Neringa Šeperienė, founder and CEO of BrachyDOSE. 

Investment details

The funding round was led by Coinvest Capital, with participation from BSV Ventures and business angel networks LitBAN and EstBAN.

• Coinvest Capital is an early-stage venture capital fund established by Lithuania’s national development institution, Investicijų ir Verslo Garantijos (INVEGA). The fund invests public capital entrusted by the EU and the Republic of Lithuania. Its recent portfolio includes Astrolight, Commody, Airvolve and Pixevia.

• BSV Ventures invests in early-stage R&D-focused individuals and teams solving complex technical challenges with large potential for commercial application. BSV Ventures targets industries such as biotech, space technology, and artificial intelligence. 

The investment will support BrachyDOSE in completing the CE and Medical Device Regulation (MDR) certification process required to bring its device to market.